InvestSMART

Noxopharm Limited (ASX: NOX) - Announcements

- Current share price for NOX : $0.055

ASX company news and announcements for Noxopharm Limited (NOX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Noxopharm Limited (NOX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Noxopharm Limited (NOX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Noxopharm Limited (NOX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$17 Noxopharm Corporate Presentation 28 Jun 2021 9:29AM $0.620 $0.055 fallen by 91.13%
$17 Cleansing Notice 21 Jun 2021 3:43PM $0.675 $0.055 fallen by 91.85%
$17 Application for quotation of securities - NOX 21 Jun 2021 3:42PM $0.675 $0.055 fallen by 91.85%
$17 DARRT-2 Study Update and Clarification 10 Jun 2021 9:11AM $0.700 $0.055 fallen by 92.14%
$17 The Noxopharm Newsletter June 2021 8 Jun 2021 8:46AM $0.660 $0.055 fallen by 91.67%
$17 Noxopharm Set to Benefit From Novartis ASCO Data 4 Jun 2021 9:48AM $0.700 $0.055 fallen by 92.14%
$17 Becoming a substantial holder 31 May 2021 3:44PM $0.690 $0.055 fallen by 92.03%
$17 Change of Director's Interest Notice - FB 31 May 2021 3:42PM $0.690 $0.055 fallen by 92.03%
$17 Change of Director's Interest Notice - BP 31 May 2021 3:38PM $0.680 $0.055 fallen by 91.91%
$17 Cleansing Notice 31 May 2021 3:35PM $0.680 $0.055 fallen by 91.91%
$17 Appendix 2A 31 May 2021 3:34PM $0.680 $0.055 fallen by 91.91%
$17 Appendix 3G 31 May 2021 3:31PM $0.680 $0.055 fallen by 91.91%
$17 Noxopharm Extraordinary General Meeting Results 31 May 2021 11:13AM $0.640 $0.055 fallen by 91.41%
$17 New Independent Trial Data Supports Potential of Veyonda 31 May 2021 8:32AM $0.600 $0.055 fallen by 90.83%
$17 Noxopharm to Present to Share Cafe Hidden Gems Webinar 13 May 2021 9:52AM $0.520 $0.055 fallen by 89.42%
$17 NOXCOVID Trial Achieves Full Enrolment 12 May 2021 8:43AM $0.565 $0.055 fallen by 90.27%
$17 Cleansing Notice 7 May 2021 2:59PM $0.580 $0.055 fallen by 90.52%
$17 Appendix 2A 7 May 2021 2:58PM $0.580 $0.055 fallen by 90.52%
$17 Veyonda FDA Approved Trial to Commence 7 May 2021 8:59AM $0.485 $0.055 fallen by 88.66%
$17 Securities Trading Policy 4 May 2021 2:46PM $0.560 $0.055 fallen by 90.18%
$17 Cleansing Notice 30 Apr 2021 2:50PM $0.600 $0.055 fallen by 90.83%
$17 Appendix 2A 30 Apr 2021 2:49PM $0.600 $0.055 fallen by 90.83%
$17 Change of Director's Interest Notice - BP 30 Apr 2021 2:46PM $0.600 $0.055 fallen by 90.83%
$17 Lapsing of Unlisted Options 30 Apr 2021 2:45PM $0.600 $0.055 fallen by 90.83%
$17 Publications Positive Review of Veyonda in Chemotherapy 30 Apr 2021 8:50AM $0.600 $0.055 fallen by 90.83%

251 - 275 of 804 results

Page 11 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.